Navegar Publicación científica por "EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña"

A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy

2015- Monserrat Iglesias, Lorenzo; Ortiz Genga, Martín

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

2014- Monserrat Iglesias, Lorenzo

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy: A proof of concept study

2012- Monserrat Iglesias, Lorenzo

A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome

2014- López Fernández, María Fernanda; Batlle Fonrodona, Francisco Javier; Perez Rodriguez, Almudena; Lourés Fraga, Esther; Rodríguez Trillo, Angela; [et al.]

A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis

2013- Sánchez Ares, María; García Vidal, Marina; Espinosa Estévez, Antucho; Pardo Fernández, Julio; Vazquez Martul, Eduardo; [et al.]

A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues

2011- Rodriguez Rigueiro, Teresa; Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Aparicio Gallego, Guadalupe; [et al.]

A novel ultrasound-guided block: A promising alternative for breast analgesia

2014- López Alvarez, Servando; Diéguez García, Paula

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

2015- Calvo Martínez, Lourdes

A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)

2011- Reboredo Lopez, Margarita; Candamio Folgar, Sonia; López López, Rafael; Quintero Aldana, Guillermo; Salgado Fernández, Mercedes; [et al.]

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

2014- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Alonso-Jaudenes Curbera, Guillermo [et al.]

A phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease

2015- García Campelo, María del Rosario

A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens

2011- Valladares Ayerbes, Manuel

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

2012- Antón Aparicio, Luis Miguel; Fernández Nuñez, Natalia; Roldán Corrales, Ana Milena; Alvarez García, Augusto

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colo

2013- Valladares Ayerbes, Manuel

A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia

2014- Pita Fernandez, Salvador; Pertega Diaz, Sonia; Pedreira Andrade, José Domingo; López Calviño, Beatriz; Seoane Pillado, María Teresa; [et al.]

A randomized controlled trial to assess the efficacy and cost-effectiveness of urinary catheters with silver alloy coating in spinal cord injured patients: trial protocol

2013- Salvador de la Barrera, Sebastian

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

2011- Valladares Ayerbes, Manuel

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

2012- Calvo Martínez, Lourdes

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

2012- Sousa Regueiro, Dolores

Repositorio digital RUNA

Navegar Publicación científica por "EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña"

A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy ﻿

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) ﻿

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy: A proof of concept study ﻿

A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome ﻿

A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis ﻿

A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues ﻿

A novel ultrasound-guided block: A promising alternative for breast analgesia ﻿

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study) ﻿

A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV) ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. ﻿

A phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease ﻿

A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens ﻿

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab ﻿

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colo ﻿

A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia ﻿

A randomized controlled trial to assess the efficacy and cost-effectiveness of urinary catheters with silver alloy coating in spinal cord injured patients: trial protocol ﻿

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143) ﻿

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study ﻿

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections ﻿

A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy: A proof of concept study

A novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome

A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis

A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues

A novel ultrasound-guided block: A promising alternative for breast analgesia

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

A phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease

A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colo

A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia

A randomized controlled trial to assess the efficacy and cost-effectiveness of urinary catheters with silver alloy coating in spinal cord injured patients: trial protocol

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections